[Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy]. (2016). Farmeconomia. Health Economics and Therapeutic Pathways, 17(2), 47-58. https://doi.org/10.7175/fe.v17i2.1243